Press Releases

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020

MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the imaging science community at the 15th European Molecular Imaging Meeting (EMIM 2020) on March 24 – 27, 2020 in Thessaloniki, Greece.

Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.

This acquisition will spur the development of new drugs to treat complex neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease.

The Pistoia Alliance’s UDM Project Reaches Major Milestone

Funding from Biovia, Elsevier, GSK, Novartis, and Roche (and recently BMS), helps build a comprehensive data model and file format for chemical reactions to support Lab of The Future and AI adoption

Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors

The release announces a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Bank’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors.

Rare Disease Patient Platform Raremark Partners With TriNetX

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community. 

Streck to present new tube at TRI-CON

Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco.

2 Industry Veterans Join TrialScope Connect™ Advisory Board

TrialScope announces the appointment of Craig Lipset and Scott Ballenger to the TrialScope Connect advisory board. TrialScope Connect is an online clinical trial recruitment collective designed address the challenges stakeholders face in accurately matching patients to trials. In advance of the platform’s launch, TrialScope is accepting partner applications from sponsors, healthcare data companies and patient advocacy groups.

Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor

Rho Announces Fifth Year as Smile Train Triathlon Title Sponsor The RTP-based Contract Research Organization will continue to show its support at the charity’s 13th annual event in Wake Forest Research Triangle Park, NC ̶ February 17, 2020 ̶ Rho, an RTP-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, today announced it is the 2020 Title Sponsor of the 13th annual Smile Train Triathlon, taking place Sunday, June 28 in Wake Forest, North Carolina. This is the fifth year in a row that Rho will be the title sponsor for the event.

IDDI INTENSIFIES GLOBAL DEBATE ON THE FUTURE OF RANDOMIZED TRIALS IN CLINICAL RESEARCH

International Drug Development Institute (IDDI), a leading therapy-focused Biostatistics and eClinical Services corporation based in Belgium with offices in Boston (MA) and Raleigh (NC) announces that it is hosting a symposium to drive the debate: Are Randomized Clinical Trials Obsolete? Organized with support from the University of Louvain (UCLouvain) and the European Organisation for Research and Treatment of Cancer (EORTC) the symposium will take place at the Auditorium Museum of Fine Arts and Magritte Museum, Brussels, Belgium, on Wednesday, April 22, 2020.

Signant Health invests for growth with the opening of its new Philadelphia-area office

Greenphire and Roche Team to Address Critical Clinical Trial Patient Convenience Issues at 11th Annual SCOPE Summit

Greenphire, the global leader in financial software for clinical trials, today announced that it has teamed with top industry sponsor, Roche (SIX: RO, ROG;OTCQX: RHHBY), to address the top hurdles patients face when participating in clinical trials. T

The Open Wearables Initiative Expands Founding Team; Begins Soliciting Algorithms and Datasets for Wearable and Connected Health Technologies

OWEAR Founders Shimmer, GGIR software and algorithms author Dr. Vincent van Hees, and Nextbridge Health are now joined by non-profits Sage Bionetworks and DiMe. 

Signant Health Unveils its full Conference Line-up for SCOPE 2020

Accumen Celebrates Grand Opening of New Corporate Headquarters

Accumen relocates its company headquarters to Phoenix, joining the influx of innovative businesses moving to the Valley of the Sun.

Arvinas Selects Certara to Advance Speed and Efficiency of its Targeted Protein Degradation Research

Certara’s D360 platform enables Arvinas to accelerate lead identification and optimization processes for oncology, neurodegenerative diseases, and therapies for “undruggable” targets.

Accumen’s 3DR Labs Partners with Resonance Health to Expand its MRI Analysis Services

3DR Labs will employ Resonance Health’s FerriSmart® software to analyze liver iron concentrations from MRIs and provide summary reports.

BioIVT Appointed Worldwide Distributor of upcyte® Products for Use in In-vitro Drug Discovery and Development Studies

This new partnership will increase the quantity and range of hepatic cells that BioIVT can offer to drug researchers.

Elsevier creates free information center to bring together latest clinical research on novel coronavirus 2019-nCoV

Online information center provides one-stop access to the latest medical and scientific information from across Elsevier’s journals and clinical resources.

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Sixth Consecutive Year

Adoption of Certara’s proprietary technologies and consulting knowledge aligns with FDA’s commitment to modernizing the drug development process

WCG Acquires Statistics Collaborative, a Biostatistical Consultancy Specializing in Pharmaceutical and Biologics Clinical Trials

This transaction broadens the range of specialized services that WCG offers to clinical trial sponsors